This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and
reagents.
The assessments include:
- Sales
- Product portfolios
- Distribution tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies.
Contains 80 pages